Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

2 Nov 2022

Abstract excerpt

mRNA vaccines were the first to be authorized for use against SARS-CoV-2 and have since demonstrated high efficacy against serious illness and death. However, limitations in these vaccines have been recognized due to their requirement for cold storage, short durability of protection, and lack of access in low-resource regions. We have developed an easily-manufactured, potent self-amplifying RNA (saRNA) vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36323666
DOI: 10.1038/s41541-022-00549-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilityPMID 36323666Read ↗

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19Semantic proximity Read ↗

Circular RNA Vaccines against SARS-CoV-2 and Emerging VariantsSemantic proximity Read ↗

Vaccines’ New Era-RNA VaccineSemantic proximity Read ↗

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2Semantic proximity Read ↗

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernSemantic proximity Read ↗

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?Semantic proximity Read ↗

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read ↗

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read ↗

mRNA Vaccines Five Years After COVID-19: Lessons in Platform Design, Real-World Effectiveness, and EquitySemantic proximity Read ↗

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An OverviewSemantic proximity Read ↗

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in miceSemantic proximity Read ↗

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.